Jingfang Ju
Affiliations: | Molecular and Cellular Biology | Stony Brook University, Stony Brook, NY, United States |
Area:
Cell Biology, Oncology, Molecular BiologyGoogle:
"Jingfang Ju"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Soung YH, Chung H, Yan C, et al. (2024) Correction: Soung et al. Therapeutic Potential of Chemically Modified MiR-489 in Triple-Negative Breast Cancers. 2020, , 2209. Cancers. 16 |
Soung YH, Ju J, Chung J. (2023) The Sensitization of Triple-Negative Breast Cancers to Poly ADP Ribose Polymerase Inhibition Independent of BRCA1/2 Mutation Status by Chemically Modified microRNA-489. Cells. 13 |
Pal A, Ojha A, Ju J. (2023) Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer. International Journal of Molecular Sciences. 24 |
Yuen JG, Hwang GR, Fesler A, et al. (2023) Development of Gemcitabine-Modified miRNA Mimics as Cancer Therapeutics for Pancreatic Ductal Adenocarcinoma. Biorxiv : the Preprint Server For Biology |
Yuen JG, Hwang GR, Ju J. (2023) Analysis of MicroRNAs in Ferroptosis. Methods in Molecular Biology (Clifton, N.J.). 2712: 223-232 |
Hwang GR, Yuen JG, Fesler A, et al. (2023) Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer. Molecular Therapy Oncolytics. 28: 277-292 |
Almanzar VMD, Shah K, LaComb JF, et al. (2023) 5-FU-miR-15a Inhibits Activation of Pancreatic Stellate Cells by Reducing YAP1 and BCL-2 Levels In Vitro. International Journal of Molecular Sciences. 24 |
Patel HR, Diaz Almanzar VM, LaComb JF, et al. (2023) The Role of MicroRNAs in Pancreatitis Development and Progression. International Journal of Molecular Sciences. 24 |
Yuen JG, Fesler A, Hwang GR, et al. (2022) Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics. Molecular Therapy : the Journal of the American Society of Gene Therapy |
Liu X, Lu Y, Xu Y, et al. (2022) Corrigendum to "Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer" [Canc. Lett. 459 (2019 Sep 10) 122-134]. Cancer Letters. 215695 |